Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 5th, 2013% (William Hook/Flickr)
Engineers and physiologists at Northwestern University in Chicago developed an algorithm to improve the way health and wellness apps on smartphones track a user’s physical movements. Professor of physical medicine and rehabilitation Konrad Kording, with colleagues Stephen Antos and Mark Albert, published an advance version of their findings online in the . . . → Read More: Algorithm Improves Activity Tracking for Wellness Apps
By Alan, on November 4th, 2013% (National Institutes of Health)
A psychologist at University of Missouri in Columbia found the design of software used by physicians influences their choice of diagnostic tests when admitting new patients to hospitals, with implications for the quality of patient care and health care costs. Victoria Shaffer in Missouri’s Department of Health Sciences, with . . . → Read More: Software Design Found to Influence Lab Test Choices
By Alan, on November 4th, 2013% Lymphocyte (National Cancer Institute)
The U.S. Food and Drug Administration on Friday approved an antibody designed to treat chronic lymphocytic leukemia, when taken with chemotherapy. Obinutuzumabm — developed and marketed as the brand name Gazyva by the biotechnology company Genentech, a division of Roche in South San Francisco, California — is the first . . . → Read More: FDA Approves Leukemia Treatment, First Breakthrough Therapy
By Alan, on November 1st, 2013% (Yale School of Medicine/Wikimedia Commons)
A new challenge on InnoCentive is looking for new ways to encourage physicians to prescribe anticoagulant drugs other than the commonly used warfarin for decreasing the formation of blood clots in people with atrial fibrillation. The competition has a total purse of $7,500 and a deadline of 27 . . . → Read More: Strategy Sought to Encourage New Anticoagulant Prescriptions
By Alan, on November 1st, 2013% Emery Brown (Mass. Institute of Technology)
Engineers at Massachusetts Institute of Technology and medical researchers at Massachusetts General Hospital in Boston developed and tested in lab animals a system connecting the brain to a drug infusion device that automatically controls anesthesia drugs administered to patients in a drug-induced coma. The team led by . . . → Read More: Automated System Developed to Monitor Drug-Induced Comas
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.